Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

SDGR

Schrodinger (SDGR)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SDGR
DataOraFonteTitoloSimboloCompagnia
12/02/202522:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SDGRSchrodinger Inc
12/02/202514:30Business WireSchrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26NASDAQ:SDGRSchrodinger Inc
12/02/202500:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SDGRSchrodinger Inc
22/01/202514:30Business WireSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)NASDAQ:SDGRSchrodinger Inc
13/01/202513:00Business WireSchrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic PrioritiesNASDAQ:SDGRSchrodinger Inc
20/11/202414:30Business WireSchrödinger to Present at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
18/11/202414:30Business WireSchrödinger Broadens and Accelerates Predictive Toxicology InitiativeNASDAQ:SDGRSchrodinger Inc
13/11/202422:30Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:SDGRSchrodinger Inc
12/11/202413:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SDGRSchrodinger Inc
12/11/202412:50Business WireSchrödinger Reports Third Quarter 2024 Financial ResultsNASDAQ:SDGRSchrodinger Inc
12/11/202412:45Business WireSchrödinger Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with NovartisNASDAQ:SDGRSchrodinger Inc
04/11/202414:30Business WireSchrödinger to Present at Jefferies London Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
31/10/202413:30Business WireSchrödinger to Announce Third Quarter 2024 Financial Results on November 12NASDAQ:SDGRSchrodinger Inc
23/10/202412:01Business WireSchrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR SymposiumNASDAQ:SDGRSchrodinger Inc
09/10/202412:06Business WireSchrödinger to Present New Preclinical SGR-3515 and PRMT5-MTA Data at 2024 EORTC-NCI-AACR SymposiumNASDAQ:SDGRSchrodinger Inc
19/09/202420:18PR Newswire (US)Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law FirmNASDAQ:SDGRSchrodinger Inc
12/09/202422:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SDGRSchrodinger Inc
14/08/202414:30Business WireSchrödinger to Present at Morgan Stanley Global Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
31/07/202422:21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SDGRSchrodinger Inc
31/07/202422:05Business WireSchrödinger Reports Strong Second Quarter 2024 Financial ResultsNASDAQ:SDGRSchrodinger Inc
26/07/202413:00Business WireSchrödinger Launches Initiative to Significantly Expand Application of Computational Tools for Predictive ToxicologyNASDAQ:SDGRSchrodinger Inc
17/07/202414:58Business WireSchrödinger to Announce Second Quarter 2024 Financial Results on July 31NASDAQ:SDGRSchrodinger Inc
30/05/202422:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SDGRSchrodinger Inc
22/05/202414:30Business WireSchrödinger to Present at Jefferies Global Healthcare ConferenceNASDAQ:SDGRSchrodinger Inc
01/05/202422:00Business WireSchrödinger Reports First Quarter 2024 Financial ResultsNASDAQ:SDGRSchrodinger Inc
10/04/202414:30Business WireSchrödinger to Announce First Quarter 2024 Financial Results on May 1NASDAQ:SDGRSchrodinger Inc
20/03/202415:27Business WireSchrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National MeetingNASDAQ:SDGRSchrodinger Inc
28/02/202422:05Business WireSchrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:SDGRSchrodinger Inc
20/02/202414:30Business WireSchrödinger to Participate in Upcoming Investor ConferencesNASDAQ:SDGRSchrodinger Inc
14/02/202414:30Business WireSchrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28NASDAQ:SDGRSchrodinger Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SDGR
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network